Developing improved non-invasive imaging for assessing heart damage

Ex vivo scans of hearts from fibrotic (left) and control mice which
were administered a unique fluorescent peptide that targets collagen
type I. A striking enhancement of the damaged heart ventricles
is observed. Image: Figure 5 in study

A Monash University team has led the development of novel imaging tracers that could advance non-invasive assessment of heart damage. 

Cardiac fibrosis is a scarring process causing excess deposition of collagen in the heart, leading to distortion of its architecture and function. It is a significant disease feature in many cardiac conditions, including heart failure, atrial fibrillation (AF) and myocardial infarction (MI).

Welcome to Dr Robert Brkljača

Dr Robert Brjklača

Welcome to Dr Robert Brkljača, who has recently joined us as part of the Alfred Research Alliance -Monash Bioimaging facility! Robert is the facility manager and imaging support scientist.  Robert obtained his PhD in Chemistry at RMIT University, with a focus on natural products drug discovery.

Since completing his PhD, Robert's research has been focused on Nuclear Magnetic Resonance applications, resulting in over 50 publications. Out of work hours, Robert enjoys skiing, mountain biking, and baking.